propofol has been researched along with Hyperthyroid in 7 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperthyroidism patients experience a shorter onset time, a shorter duration, and require larger doses of rocuronium than euthyroidism patients." | 7.74 | Hyperthyroidism patients have shorter onset and duration time of rocuronium than euthyroidism patients. ( Feng, SW; Ge, YL; He, LL; Song, XJ; Wang, YG; Yang, JJ, 2007) |
| "We managed two patients with secondary hyperthyroidism due to TSH secretion from pituitary adenomas using total intravenous anesthesia with propofol and fentanyl." | 7.72 | [Anesthetic management with propofol, fentanyl TCI and BIS in two cases of secondary hyperthyroidism due to TSH secretion from pituitary adenomas]. ( Kamata, K; Nagata, O; Nishiyama, K; Ozaki, K; Ozaki, M; Uezono, S, 2003) |
| "We investigated propofol pharmacokinetics in a patient with secondary hyperthyroidism caused by thyroid stimulating hormone (TSH) producing pituitary adenoma." | 7.71 | [Propofol pharmacokinetics in a patient with TSH producing pituitary adenoma]. ( Ishizuka, S; Kobayashi, T; Tsubokawa, T; Yamamoto, K, 2001) |
| "We investigated propofol pharmacokinetics in seven hyperthyroid (Group H) and eight euthyroid (Group E) patients undergoing elective subtotal thyroidectomy." | 7.70 | Propofol clearance and distribution volume increase in patients with hyperthyroidism. ( Kobayashi, T; Tsubokawa, T; Yamamoto, K, 1998) |
| "Hyperthyroidism patients experience a shorter onset time, a shorter duration, and require larger doses of rocuronium than euthyroidism patients." | 3.74 | Hyperthyroidism patients have shorter onset and duration time of rocuronium than euthyroidism patients. ( Feng, SW; Ge, YL; He, LL; Song, XJ; Wang, YG; Yang, JJ, 2007) |
| "We managed two patients with secondary hyperthyroidism due to TSH secretion from pituitary adenomas using total intravenous anesthesia with propofol and fentanyl." | 3.72 | [Anesthetic management with propofol, fentanyl TCI and BIS in two cases of secondary hyperthyroidism due to TSH secretion from pituitary adenomas]. ( Kamata, K; Nagata, O; Nishiyama, K; Ozaki, K; Ozaki, M; Uezono, S, 2003) |
| "Serum samples from patients with hypo- (n=33) and hyperthyroidism (n=33) and also from healthy volunteers (control group; n=9) were spiked with propofol to a total (bound + unbound propofol) concentration of 10 microg/ml." | 3.71 | 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction. ( Calvo, R; de la Fuente, L; Jauregizar, N; Lukas, JC; Suárez, E; Vázquez, JA, 2002) |
| "We investigated propofol pharmacokinetics in a patient with secondary hyperthyroidism caused by thyroid stimulating hormone (TSH) producing pituitary adenoma." | 3.71 | [Propofol pharmacokinetics in a patient with TSH producing pituitary adenoma]. ( Ishizuka, S; Kobayashi, T; Tsubokawa, T; Yamamoto, K, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de la Fuente, L | 1 |
| Lukas, JC | 1 |
| Vázquez, JA | 1 |
| Jauregizar, N | 1 |
| Calvo, R | 1 |
| Suárez, E | 1 |
| Kamata, K | 1 |
| Nagata, O | 1 |
| Ozaki, K | 1 |
| Nishiyama, K | 1 |
| Uezono, S | 1 |
| Ozaki, M | 1 |
| Wang, YG | 1 |
| Song, XJ | 1 |
| Feng, SW | 1 |
| Ge, YL | 1 |
| Yang, JJ | 1 |
| He, LL | 1 |
| Tsubokawa, T | 2 |
| Yamamoto, K | 2 |
| Kobayashi, T | 2 |
| Matsumoto, S | 1 |
| Unoshima, M | 1 |
| Takeshima, N | 1 |
| Yamamoto, H | 1 |
| Yoshitake, S | 1 |
| Noguchi, T | 1 |
| Ishizuka, S | 1 |
| Nishio, W | 1 |
| Takahata, O | 1 |
| Yamamoto, Y | 1 |
| Mamiya, K | 1 |
| Iwasaki, H | 1 |
7 other studies available for propofol and Hyperthyroid
| Article | Year |
|---|---|
'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction.
Topics: Adult; Aged; Anesthetics, Intravenous; Blood Proteins; Cholesterol; Female; Humans; Hyperthyroidism; | 2002 |
[Anesthetic management with propofol, fentanyl TCI and BIS in two cases of secondary hyperthyroidism due to TSH secretion from pituitary adenomas].
Topics: Adenoma; Anesthesia, Intravenous; Fentanyl; Humans; Hyperthyroidism; Male; Middle Aged; Monitoring, | 2003 |
Hyperthyroidism patients have shorter onset and duration time of rocuronium than euthyroidism patients.
Topics: Adolescent; Adult; Androstanols; Body Temperature; Humans; Hyperthyroidism; Middle Aged; Neuromuscul | 2007 |
Propofol clearance and distribution volume increase in patients with hyperthyroidism.
Topics: Adult; Anesthetics, Intravenous; Blood Proteins; Female; Hemoglobins; Humans; Hyperthyroidism; Male; | 1998 |
[Hemodynamic effects of propofol as an anesthesia induction agent in hyperthyroidism patients on chronic beta-blocker].
Topics: Adrenergic beta-Antagonists; Adult; Anesthetics, Intravenous; Drug Interactions; Female; Hemodynamic | 2000 |
[Propofol pharmacokinetics in a patient with TSH producing pituitary adenoma].
Topics: Adenoma; Anesthesia Recovery Period; Anesthesia, General; Anesthetics, Intravenous; Half-Life; Human | 2001 |
[Perioperative management using propofol in a patient with uncontrolled preoperative hyperthyroidism].
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Female; Humans; Hyperthyroidism; Periopera | 2001 |